Congressional Stock Trades & Disclosures
Steve Chabot is a U.S. Representative, a Republican representing OH. As of June 2015, Bullish Whales has tracked 15 disclosed stock trades across 15 companies, representing $144.51K in disclosed transaction value, each filed publicly under the STOCK Act.
About Chabot's congressional trading
Chabot's disclosed activity shows a buy-leaning pattern, with 8 purchases and 7 sales (a buy-to-sell ratio of 1.14). Chabot has traded LEN, SGMA, and DAKT most frequently among disclosed positions.
On the Bullish Whales Score, which ranks members of Congress by how worth-following their disclosed buys have been relative to peers, Chabot rates 49 out of 100, a Mixed reading. The score weights a member's realized track record (80%) and conviction in repeat positions (20%); it is a descriptive research signal drawn from public filings, not investment advice.
Chabot's most recent disclosed trade was a purchase of Enact Holdings Inc (ACT) from May 2015. Each trade below links to its filing, an estimated price range, and post-trade performance versus the market.
Trading activity
Disclosed trades & legislation
| Company | Type | Size | Traded | Est. price | Change |
|---|---|---|---|---|---|
 ACTEnact Holdings Inc | Buy | $1,001 - $15,000 | 26 MAY 2015 | N/A | — |
 MMSIMerit Medical Systems Inc | Sell | $15,001 - $50,000 | 26 MAY 2015 | $20.28 | +199.06% |
 UAUnder Armour Inc C | Buy | $1,001 - $15,000 | 26 MAY 2015 | N/A | — |
 LENLennar Corporation | Buy | $1,001 - $15,000 | 26 MAY 2015 | $37.06 | +141.37% |
 DNRDNR | Sell | $1,001 - $15,000 | 26 MAY 2015 | N/A | — |
 REGNRegeneron Pharmaceuticals Inc | Buy | $1,001 - $15,000 | 26 MAY 2015 | $502.48 | +23.18% |
 MPXMarine Products Corporation | Sell | $1,001 - $15,000 | 26 MAY 2015 | $3.81 | +114.65% |
 DAKTDaktronics Inc | Sell | $1,001 - $15,000 | 26 MAY 2015 | $8.90 | +118.23% |
 TRIPTripAdvisor Inc | Buy | $1,001 - $15,000 | 26 MAY 2015 | $69.16 | -82.74% |
 NFLXNetflix Inc | Buy | $1,001 - $15,000 | 26 MAY 2015 | $8.80 | +826.44% |
Congressional trading news
The latest news on congressional stock trading, across all members, will appear here as our newsroom publishes it.
Steve Chabot congressional trading FAQ
Can Steve Chabot legally trade stocks?
Yes. Members of Congress are permitted to buy and sell stocks, but the 2012 STOCK Act requires them to publicly disclose each transaction, generally within 45 days. Bullish Whales compiles Steve Chabot's disclosures so the public can review them.
Where does Bullish Whales get Steve Chabot's trading data?
Every trade shown is sourced from official Periodic Transaction Reports filed under the STOCK Act. Amounts are reported as ranges, and estimated prices and post-trade returns are derived from end-of-day market data.
How can I track Steve Chabot's stock trades?
Bullish Whales tracks every stock trade Steve Chabot discloses under the STOCK Act on this page, including the company, the disclosed amount range, and post-trade performance. New filings appear here as they are reported, generally within 45 days of the trade.
How many stock trades has Steve Chabot disclosed?
Bullish Whales has tracked 15 disclosed trades by Steve Chabot across 15 companies.
Which stocks does Steve Chabot trade most?
Steve Chabot's most frequently disclosed positions include LEN, SGMA, DAKT, ACT, and NFLX. The full list of companies and individual filings is shown on this page.
What was Steve Chabot's most recent stock trade?
Steve Chabot most recently bought Enact Holdings Inc (ACT) in May 2015, according to public STOCK Act filings tracked by Bullish Whales.
What is Steve Chabot's Bullish Whales Score?
Steve Chabot has a Bullish Whales Score of 49 out of 100 (Mixed). The score ranks members by how worth-following their disclosed buys have been, weighting realized track record (80%) and conviction (20%). It is a descriptive research signal, not investment advice.
Browse all members of Congress who trade stocksSee which stocks Congress tradesCongressional trading overview
Trades reflect disclosures filed under the STOCK Act and are provided for informational purposes only, not investment advice. Amounts are ranges from official filings; estimated prices and post-trade returns are derived from end-of-day market data and may be revised as filings are amended.